Concepedia

Fanli Zheng

FZ

Statistics

Publications

3

Citations

143

H-Index

3

Active since

2022

Affiliations

Zhejiang Chinese Medical University(Current)

Zhejiang University

Fanli Zheng is an author at Zhejiang Chinese Medical University specializing in pharmacology, molecular pharmacology, and pi3k inhibitors.

Publications per year

2022–2024

3

Publications

3

Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway

Huanwu Hong, Siyue Lou, Fanli Zheng et al. · Phytomedicine · 2022 · 97 citations

, , +16

Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer

Yanan Zheng, Siyue Lou, Jun Lu et al. · Cell Death and Disease · 2024 · 30 citations · Full text

, , +17

Discovery of Highly Selective and Orally Bioavailable PI3Kδ Inhibitors with Anti-Inflammatory Activity for Treatment of Acute Lung Injury

Yongmei Tang, Fanli Zheng, Xiaodong Bao et al. · Journal of Medicinal Chemistry · 2023 · 16 citations · Full text

, , +14

1–3 of 3